Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 101 - 150 out of 3,264

Document Document Title
WO/2021/160564A1
Proposed are allulose concentrates in solid amorphous form, which are characterised in that they contain at least approximately 20 wt. % allulose. Also proposed is a method for producing said concentrates.  
WO/2021/158932A1
A glucose in solid form containing a matrix phase and a plurality of carbohydrate crystals within said matrix phase, the matrix phase containing amorphous glucose and water, wherein the carbohydrate crystals comprise glucose and optional...  
WO/2021/034774A9
Disclosed are methods for treating a cancer and/or modulating immune CD4+ T cell mediated therapies comprising administering to a subject a fucose. In one aspect, disclosed herein are methods of modulating major histocompatibility comple...  
WO/2021/148611A1
The present inventive concept relates to a genetically modified cell enabled for the production of an oligosaccharide, preferably, an HMO, comprising a recombinant nucleic acid encoding a protein of the MFS superfamily; and methods using...  
WO/2021/148620A1
The present invention relates to the field of recombinant production of biological molecules in genetically modified cells. More particularly, it relates to a method for recombinant production of human milk oligosaccharides (HMO) using a...  
WO/2021/126140A1
An esterification process that uses an acetic acid composition from a wood acetylation process as a reactant. Even though the acetic acid composition contains impurities, such as ethyl acetate, methyl acetate, acetaldehyde, acetone, terp...  
WO/2021/126142A1
An esterification process that uses an acetic acid composition from a wood acetylation process as a reactant. Even though the acetic acid composition contains impurities, such as ethyl acetate, methyl acetate, acetaldehyde, acetone, terp...  
WO/2021/122793A1
The present invention relates to disaccharide compounds and their use as enhancers of transmucosal drug uptake.  
WO/2021/122103A1
The present invention relates to a method for producing a human milk oligosaccharide (HMO) containing at least one HMO compound, characterized in that an aqueous solution containing the at least one HMO compound and at least one acid is ...  
WO/2021/110709A1
Process for the preparation of a galacto-oligosaccharide preparation, which process comprises the step of contacting a lactulose-containing feed with a beta-galactosidase derived from Papiliotrema terrestris. The resulting galacto-oligos...  
WO/2021/107522A2
The present application relates to a novel composition for preparing allulose and a method for preparing allulose by using same  
WO/2021/094133A2
The present invention relates to a method for producing 2'-fucosyllactose, an enzyme selectively cleaving the alpha-1,3-C-O bond of fucosylated carbohydrates and its use for the production of 2' fucosyllactose, a host cell heterologously...  
WO/2021/094459A1
The present invention relates to a method for drying human milk oligosaccharides (HMOs). More specifically, the present invention is related to a method of roller drying or drum drying of human milk oligosaccharides in a simple and econo...  
WO/2021/085317A1
The present invention allows cell culturing while the cells are suspended, and is configured for easy recovery of the cultured cells. An additive for suspension culture according to an embodiment is a medium additive that is added to a m...  
WO/2021/075882A1
The present invention relates to a coagulant that is added to effectively recover a sugar solution from a saccharified product that contains insoluble saccharified residues composed mainly of lignin, and monosaccharides after acidic sacc...  
WO/2021/075538A1
The present invention provides: a crystalline 2,4-crosslinked common intermediate useful for producing a plurality of ENA monomers; a method for stereoselectively producing said intermediate; and a method for efficiently producing indivi...  
WO/2021/066159A1
The present invention addresses the problem of providing: a sugar composition suitable for a cyclic tetrasaccharide-containing starch syrup which has low viscosity, low water activity, and low colorability, which is low in calories, and ...  
WO/2021/064629A1
The present invention relates to the separation and isolation of neutral human milk oligosaccharides (HMOs) from the reaction milieu in which they are produced, preferably from a fermentation broth, comprising the steps of: i) optionally...  
WO/2021/045968A1
This specification relates to a process for preparing a purified human milk oligosaccharide ("HMO") from an HMO-containing solution (e.g., a fermentation broth) by a process comprising removal of an antifoam agent, and a product of such ...  
WO/2021/043540A1
Disclosed are non-sporulating Bacillus cells for the production of a sialylated oligosaccharide wherein said Bacillus cell has been genetically engineered to possess a lactose permease, a CMP-NeuNAc biosynthesis pathway and a sialyltrans...  
WO/2021/039833A1
The present invention addresses the problem of providing a novel means for preventing the inhibition of the proliferation of keratinocytes even when the keratinocytes begin to contact with each other. The present invention can solve th...  
WO/2020/260028A1
The invention relates to a process for separating xylose in the liquid phase from a mixture of C5 and C6 sugars comprising at least xylose and glucose, by adsorbing the xylose on a zeolite adsorbent which is based on FAU zeolite crystals...  
WO/2020/260027A1
The invention relates to a process for separating glucose in the liquid phase from a mixture of C5 and C6 sugars comprising at least xylose and glucose, by adsorbing the glucose on a zeolite adsorbent which is based on FAU zeolite crysta...  
WO/2020/249512A1
Disclosed are non-sporulating Bacillus cells for the production of a fucosylated oligosaccharide as well as a method for producing a fucosylated oligosaccharide, wherein said Bacillus cell has been genetically engineered to possess a lac...  
WO/2020/243746A1
A method has now been found for the preparation of calcium, magnesium, and zinc salts of sugar acids, this being the object of the present invention, which is characterized in that the method may include providing a sugar and oxidizing t...  
WO/2020/233958A1
A method for the purification of an oligosaccharide, preferably a neutral human milk oligosaccharide (HMO) or a sialylated HMO, from a fermentation broth, the method comprising: - providing a fermentation broth which contains the oligosa...  
WO/2020/210027A1
The disclosure provides for methods of treating pain and neuroinflammatory pain conditions with certain oligosaccharides.  
WO/2020/205034A1
Disclosed are a method of preparing a saccharide that contains a 3-fluoro-sialic acid and a method of bonding it to a homogeneous antibody. Also within the scope of this invention are compounds each containing a 3-fluoro-sialic acid, mon...  
WO/2020/191620A1
The personal care compositions or cosmetic systems using reduced level or no preservative and/or surfactant, including skin care essences, lotions, creams and moisturizing liquids and uses thereof.  
WO/2020/189859A1
The present application relates to a novel allulose-derived compound and an acid-resistant composition comprising same.  
WO/2020/180158A1
The present invention relates to a novel compound comprising a galactose trigger moiety and cyclopropabenzindole (CBI), and an antibody-drug conjugate prepared by using same.  
WO/2020/175440A1
The present invention provides a method for producing a sugar chain, which achieves an excellent yield of a stereocontrolled sugar chain. The present invention also provides building blocks for sugar donors and for sugar acceptors, which...  
WO/2020/169782A1
The present invention relates to modified monosaccharide compounds implemented in methods for labeling and/or detecting an eukaryotic cell from a multicellular organism. It also relates to such modified monosaccharide compounds implement...  
WO/2020/168421A1
The invention provides cyclodextrin inclusion complexes of cannabis extracts, cannabinoids and cannabis terpenes, and methods of making such complexes. The cyclodextrin inclusion complexes include a host and guest compounds. The host may...  
WO/2020/148693A1
It is provided i) an amorphous carbohydrate with improved chemical stability and/or physical features, ii) a method for producing an amorphous carbohydrate with improved chemical stability and/or physical features, and iii) a method for ...  
WO/2020/146523A1
Provided herein are compositions of trehalose phospholipids and uses thereof, e.g., compounds and compositions comprising 6,6'-diphosphatidyltrehalose (diPT) and analogs thereof with modifications of the diPT chemical scaffold, that bind...  
WO/2020/141032A1
The invention relates to the field of nutritional ingredients, in particular to economically attractive methods for producing hypoallergenic galactooligosaccharides (HA-GOS) and the use thereof in food and feed items. Provided is a metho...  
WO/2020/127156A1
The present invention relates to an improved process to produce a specific and very efficient epoxidation-catalyst (1,2:4,5-Di-O-isopropylidene-β-D-erythro-2,3-hexodiulo-2,6- pyranose).  
WO/2020/127140A1
The present invention relates to a method for separating biomass from a solution comprising biomass and at least one oligosaccharide.comprising providing the solution comprising biomass and oligosaccharides.lowering the pH value of the s...  
WO/2020/132096A1
The invention provides methods for preparing antibodies and antibody derivatives with controlled levels of core fucosylation. In one aspect, provided herein is a method of controlling the level of afucosylation of an antibody or antibody...  
WO/2020/127417A2
The present invention relates to methods for producing 3-fucosyllactose (3-FL) as well as novel fucosyltransferases, more specifically novel lactose binding alpha-1,3-fucosyltransferase polypeptides, and their applications. Furthermore, ...  
WO/2020/114850A1
The invention relates to a continuous method for obtaining a crystalline monosaccharide, comprising: continuous crystallization of the monosaccharide in a main crystallizer (10), wherein crystallization by evaporation and/or crystallizat...  
WO/2020/111851A1
The present application relates to a method for preparing a D-psicose crystal comprising 98%(w/w) or more of D-psicose and 0.05%(w/w) or less of ethanol on the basis of 100%(w/w) of the entire crystal, the method comprising: a first step...  
WO/2020/098659A1
The present invention relates to a method for removing impurities in a xylose mother liquor. A xylose mother liquor produced during xylose production is used as a raw material, and the xylose mother liquor is pretreated by using a lytic ...  
WO/2020/097446A1
The present disclosure relates to methods of feeding animals by providing feed additives that modulate the gut microbiome to prevent or treat dysfunctions in a gastrointestinal barrier. The present disclosure further relates to methods o...  
WO/2020/097458A1
The present disclosure relates oligosaccharide preparations suitable for use in nutritional compositions such as animal feed and methods of manufacturing the described oligosaccharide preparations. The present disclosure further relates ...  
WO/2020/091423A1
The present invention provides a novel phytochemical-fructooligosaccharide conjugate having a structure in which a phytochemical in the form of phenolic acid is conjugated to a portion of saccharides constituting a fructooligosaccharide ...  
WO/2020/079146A1
Crystalline form II of 2'-O-fucosyl lactose having an X-ray powder diffraction pattern comprising three reflections at 2θ angles (13.65 ± 0.20)°, (16.98 ± 0.20)° and (18.32 ± 0.20)°, determined at a temperature of 25 °C with Cu-K...  
WO/2020/074635A1
The present invention describes a syrup of tagatose and galactose as main components together with other secondary products such as glycerol, oligosaccharides and other sugars in a minority amount.  
WO/2020/062156A1
Disclosed by the present application is a continuous flow catalytic reactor, an assembling method therefor and an application thereof. The continuous flow catalytic reactor comprises a reaction container, a filler material packaged in th...  

Matches 101 - 150 out of 3,264